OHP: What is it?

The hemp market has changed considerably in recent years.

For a long time, CBD represented the bulk of cannabinoid products marketed outside of cannabis containing significant concentrations of THC.

This situation has gradually changed.

New molecules and new formulations have emerged, giving rise to what are commonly called neo-cannabinoids.

OHP is one of the names recently encountered in this field.

But one clarification is essential from the outset: unlike CBD, CBG or delta-9-THC, the name OHP is not, to our knowledge, a sufficiently documented standard scientific name allowing one to unambiguously identify a molecule simply from these three letters.

Therefore, caution is advised when encountering very specific statements regarding:

• its chemical structure;
• its power;
• its origin;
• its effects;
• its pharmacology;
• its toxicology;
• its legality.

To truly understand the nature of an OHP product, its analytical composition and the manufacturer's documentation are essential.

Why is OHP considered a neo-cannabinoid?

The term neo-cannabinoid is primarily used in the trade to refer to a new generation of cannabinoids, derivatives or formulations that have emerged since the rise of CBD.

This is not necessarily a uniform pharmacological or legal category.

This term can encompass molecules with very different characteristics.

Some are naturally present in trace amounts in cannabis.

Others can be obtained by transforming a cannabinoid used as a precursor.

Other names correspond to commercial formulations or designations.

This distinction is particularly important with OHP.

A commercial name does not automatically allow one to deduce the molecular structure of the product.

OHP: Why is this new generation generating so much interest?

The success of neo-cannabinoids is partly explained by the rapid evolution of the hemp market.

Consumers have gradually discovered a much wider range of cannabinoids and flavor profiles.

CBD, CBG, CBN and various newer molecules have contributed to the evolution of the product range.

At the same time, successive changes to French regulations concerning certain cannabinoids have profoundly transformed the available catalogue.

New references have appeared while others have disappeared.

The OHP is part of this particularly dynamic context.

This also explains why research such as:

OHP cannabinoid

OHP France

OHP legal

OHP effects

OHP review

OHP vs CBD

OHP neo-cannabinoid

or

What is OHP?

begin to appear.

The problem is that the available information does not always progress as quickly as marketing.

OHP: a cannabinoid that is still poorly documented

This is probably the most important information on this page.

New cannabinoids appearing on the market may have much less scientific backing than CBD or THC.

For the OHP, this problem is even more important when the commercial name does not allow for the immediate identification of a molecule that is the subject of abundant scientific literature.

This means that we need to distinguish three levels of information.

Analytical information

They come mainly from laboratory analyses and allow us to know the composition of a given product.

Scientific information

They come from published studies that allow for the study of a precisely identified molecule.

The testimonies

They correspond to experiences reported by users.

These three categories do not possess the same scientific value.

A testimony cannot demonstrate the pharmacology of a substance.

What are the effects of OHP?

The search for "OHP effects" is likely to become one of the main questions surrounding this term.

However, it would be premature to provide a list of guaranteed effects.

When the precise chemical identity of a substance is insufficiently documented publicly, it becomes impossible to extrapolate with certainty its interaction with the organism.

The effects reported on the Internet should therefore be considered as testimonials and not as proven medical properties.

This distinction also helps to avoid a common problem in the world of new cannabinoids: the reproduction of the same information from one site to another until a hypothesis is eventually presented as scientific data.

Is OHP psychoactive?

The question depends directly on the actual composition of the formulation marketed under this name.

A cannabinoid product that may alter perception, alertness, reflexes, or judgment should be considered with the precautions applicable to psychoactive substances.

In the absence of sufficiently robust data to precisely establish the pharmacological profile of OHP, it is preferable to apply a principle of caution.

In particular, one should never assume that a new cannabinoid is non-psychoactive simply because it is not delta-9-THC.

OHP and the endocannabinoid system

To understand why cannabinoids can produce very different effects, we need to look at the endocannabinoid system.

The human body notably possesses cannabinoid receptors called CB1 and CB2.

Different cannabinoids can interact directly or indirectly with this system.

But not all molecules interact in the same way.

Delta-9-THC notably has a known activity on CB1 receptors.

CBD has a different and much more complex pharmacological profile.

For a new substance, specific studies are needed before its affinity for CB1 or CB2 can be precisely stated.

That is why we avoid attributing to OHP an affinity value or a precise mechanism without corresponding scientific data.

OHP vs CBD: what are the differences?

CBD , or cannabidiol, is today one of the best-known cannabinoids among the general public .

The OHP is in a very different situation.

CBD has a perfectly defined chemical identity and benefits from a significant body of scientific research.

OHP is a much more recent term in the neo-cannabinoid trade.

Therefore, OHP should not be considered as simply a "stronger" version of CBD.

This comparison would be misleading.

The level of available knowledge is not comparable.

OHP vs THC

The comparison with THC should also be approached with caution.

Delta-9-tetrahydrocannabinol has been studied for several decades.

Its main pharmacological characteristics are known.

For the OHP, it would be premature to make statements such as:

"OHP is twice as potent as THC"

"OHP equivalent to THC"

Or

"OHP is less potent than THC.".

To establish this type of comparison, it would be necessary to know precisely the molecule being studied and to have comparable pharmacological data.

A sensation reported by a user does not allow for the establishment of a scientific power scale.

OHP vs 10-OH-HHC

Consumers interested in new cannabinoids can also compare OHP and 10-OH-HHC.

Here again, we need to distinguish between the different terms.

10 -OH-HHC corresponds to a much more descriptive chemical name referring to a hydroxylated compound related to HHC.

OHP does not necessarily allow the same identification.

Therefore, the two names should not be considered synonymous.

They should also not be compared solely on the basis of the concentrations displayed on the products.

A 20% OHP product is not necessarily comparable to a product containing 20% ​​of another cannabinoid.

Concentration and power: beware of confusion

In product information sheets for neo-cannabinoids, concentrations are regularly expressed as a percentage.

10%.

20%.

30%.

40%.

Sometimes more.

These figures provide information on the stated concentration of a formulation, provided that it is correctly defined and verified.

They alone do not allow us to determine its pharmacological potency.

Let's take two different molecules, each present at a concentration of 20%.

This does not mean at all that they will produce identical activity.

The potency depends in particular on the pharmacology of each substance.

That is why concentration and potential intensity should not be used as synonyms.

OHP: Why laboratory analysis is essential

For Buddha Farm's, the issue of testing takes on particular importance with neo-cannabinoids.

The more recent a molecule is, the more important transparency becomes regarding its composition.

A certificate of analysis can reveal several characteristics of the product.

Ideally, it should identify:

• the laboratory;
• the product;
• the batch number;
• the date of the analysis;
• the cannabinoids sought;
• the cannabinoids detected;
• their concentrations.

Depending on the type of analysis performed, other controls may also concern different contaminants.

What is a COA?

COA stands for Certificate ofAnalysis.

This is a document produced by a laboratory following the analysis of a sample.

In the cannabinoid sector, this document plays an important role.

It allows us to compare the claims on the label with the results obtained during the analysis.

For a recent product like OHP, the COA takes on even greater importance.

However, it is necessary to ensure that it corresponds to the product in question.

Check the batch number

A certificate of analysis is only truly valuable for a given product if a link can be established between the analyzed sample and the marketed product.

The batch number is one of the means by which this verification can be carried out.

The same certificate used for several years for different productions does not provide the same level of transparency as an analysis associated with an identifiable production.

For consumers who want to understand precisely what they are buying, this detail is important.

Why analyze new cannabinoids?

An analysis helps to identify a major market problem: the potential gap between the trade name and the actual composition.

A label may advertise OHP.

But what exactly does the formulation contain?

What concentration was measured?

What other cannabinoids are present?

Does delta-9-THC exist?

Does the stated concentration correspond to the analytical result?

Only a suitable analysis can properly answer these questions.

OHP and purity

The term "purity" is also widely used in the sector.

A raw material advertised as very pure must be able to be documented.

However, high cannabinoid purity does not automatically mean that all quality criteria are met.

It is also necessary to consider the substances that make up the remaining fraction of the product.

For some processes, analyses of residual solvents or by-products may be relevant.

OHP: natural, semi-synthetic or synthetic?

This question cannot be reliably answered using only the three letters "OHP".

It is necessary to know the substance and its manufacturing process.

Vocabulary is also important.

A molecule may be present naturally in trace amounts but be manufactured commercially by transforming another cannabinoid.

Therefore, saying that a compound "exists in cannabis" does not necessarily mean that the commercial product was directly extracted from the plant in its final form.

Understanding semi-synthetic cannabinoids

The term semi-synthetic is generally used when a natural compound serves as a raw material before being chemically transformed.

In the hemp sector, CBD can, for example, serve as a precursor to various transformations.

The final product then has a different structure from the starting compound.

This type of manufacturing makes mastering the process particularly important.

A chemical transformation requires rigorous control of raw materials, reactions, purification and the final product.

Why does manufacturing matter so much?

When we talk about traditional hemp flowers, the bulk of the cannabinoid composition comes directly from the plant.

With certain formulations of neo-cannabinoids, an additional step is involved.

The cannabinoid can be produced or processed separately before being incorporated into a final product.

Quality therefore depends on both:

• support;
• of the cannabinoid used;
• of the transformation process;
• of purification;
• of the formulation;
• of the final inspection.

This chain explains why two products with the same brand name can have significant differences.

OHP products: what categories can be found?

Depending on the manufacturers and the ranges available, neo-cannabinoids can be integrated into different types of products.

These include enriched flowers, resins and various concentrated formulations.

However, the format alone does not allow us to determine quality.

Each product must be evaluated based on its composition and analyses.

OHP Flowers

An OHP flower must be distinguished from a flower that has naturally developed a high content of this compound.

In the world of neo-cannabinoids, the flowers may consist of a hemp base to which a formulation is added after harvest.

The percentage displayed then corresponds to the stated concentration of the enriched product.

This information is important for transparency.

A mention such as "OHP flower 20%" therefore does not necessarily mean that the plant naturally synthesized 20% of this substance during its growth.

The importance of the flower used as a support

Even when a cannabinoid formulation is added after harvest, the quality of the starting flower remains important.

It notably influences:

• appearance;
• the structure;
• density;
• the initial aromatic profile;
• the quality of the manicure;
• conservation.

Modern genetics can exhibit very different aromatic profiles.

Some are fruity.

Others are lemon-flavored.

Some mention the Kush, Haze, Diesel, Gelato or Runtz families.

This diversity makes it possible to build different aromatic identities around the same range.

OHP Indoor

The term "Indoor" indicates cultivation carried out in a controlled indoor environment.

This method allows the producer to precisely manage various parameters such as light, humidity, ventilation, or temperature.

It is often associated with premium ranges because it allows for a certain homogeneity of flowers.

However, this does not automatically guarantee the final quality.

The producer's expertise and the steps following the harvest remain essential.

OHP Greenhouse

Greenhouse cultivation, or growing in greenhouses, represents another approach.

It typically combines natural light with partial environmental control.

This method can provide an interesting compromise between controlling conditions and utilizing the sun.

Once again, Indoor or Greenhouse primarily describes a cultivation method and not an absolute guarantee of quality.

OHP Resin

OHP resins can constitute another category of enriched products.

Their texture and appearance can vary considerably depending on their formulation.

Some have a soft and malleable texture.

Others are drier or more crumbly.

Some may have a bolder font.

The aromatic profile depends on the base, the terpenes and the chosen formulation.

Why are aromatic profiles important?

Consumers of hemp products often seek a specific aromatic identity.

Modern genetics and formulations allow us to rediscover very different universes:

• fruity;
• tropical;
• lemony;
• floral;
• earthy;
• wooded;
• spicy ;
• creamy;
• gourmand ;
• Diesel;
• Kush.

These descriptions relate to the sensory profile of the product, and not its pharmacological intensity.

This distinction is important.

OHP and terpenes

Terpenes are aromatic molecules found in many plants.

They are found in citrus fruits, flowers, spices, conifers and cannabis.

They contribute to the olfactory identity of a variety.

Terpenes commonly found in hemp include:

• myrcene;
• limonene;
• beta-caryophyllene;
• pinene;
• linalool.

However, the actual presence and concentration of each terpene depends on the product.

The name of a variety does not constitute a terpene analysis.

Legal OHP in France: what does the regulation say?

The search term "OHP legal France" deserves a particularly cautious response.

The market for new cannabinoids has undergone numerous regulatory changes.

Several substances that were previously available commercially were subsequently subject to classification measures.

Therefore, one should never infer the legality of a product simply from the fact that it is sold on the Internet.

In the case of OHP, there is an additional difficulty: the name must be linked to a precise chemical composition before its legal status can be properly analyzed.

Can we say that OHP is a legal neo-cannabinoid?

Not solely based on the name OHP.

Such a statement requires knowing precisely the molecule or molecules composing the product.

French drug regulations do not function solely as a list of brand names.

It targets substances and, in some cases, their isomers, derivatives, esters, ethers or chemical families.

A change in marketing name obviously does not change the structure of a molecule.

That is why regulatory analysis must always start from the actual composition.

Why are some cannabinoids becoming banned?

The emergence of new cannabinoids poses a challenge for health authorities.

A substance can be marketed even when little toxicological data is available.

The authorities can then analyze the reports and available knowledge.

If they consider that the substance presents a risk justifying its classification, the regulations may change.

This situation has already occurred for several cannabinoids.

She explains why legal information published on a shop must always include an update date.

OHP and THC: beware of the finished product

Even when the main cannabinoid in a reference has a special status, its entire composition must be examined.

A product can contain several cannabinoids.

The presence of THC must be specifically checked analytically.

Therefore, it is not enough to verify the substance highlighted in the trade name.

Compliance relates to the product actually sold.

OHP and driving

A rule of caution must be applied to products that may impair psychomotor abilities.

You should not drive after using a psychoactive substance.

This includes, in particular:

• attention;
• reflexes;
• coordination;
• perception;
• the judgment.

Risk should not be assessed solely on the basis of the user's subjective perception.

A person may feel relatively normal while some abilities remain impaired.

OHP and saliva test

This question comes up frequently for all new cannabinoids:

"Is HPO detectable by saliva testing?"

It would be irresponsible to guarantee a negative outcome.

The answer depends in particular on:

• of the actual composition;
• of the possible presence of THC;
• metabolites;
• of the test used;
• possible cross-reactions.

A product marketed as OHP may also contain other cannabinoids.

Therefore, any promise of the type "100% undetectable" should be viewed with great caution.

OHP: What are the risks?

Since specific data available on OHP are limited, it is not possible to establish a complete and reliable toxicological profile.

It is precisely this uncertainty that must be taken into account.

For cannabinoid substances that may be psychoactive, various adverse effects may be reported or anticipated depending on the composition:

• dizziness;
• drowsiness;
• anxiety ;
• confusion ;
• coordination disorders;
• modification of perception;
• nausea;
• faintness ;
• palpitations.

This list does not mean that OHP systematically causes these manifestations.

She explains why new cannabinoids should not be presented as risk-free in the absence of proper studies.

OHP and medications

The issue of drug interactions is particularly important.

Many compounds are metabolized by the liver.

Different cannabinoids can also influence certain enzymatic pathways.

Without specific data on a precisely identified substance, it is impossible to guarantee the absence of interaction.

A person undergoing medical treatment should therefore seek advice from a healthcare professional before any exposure to a new cannabinoid.

OHP and alcohol

Combining psychoactive substances can make their effects more unpredictable.

Alcohol already impairs coordination, judgment, and reflexes.

Combining it with another substance that could affect these functions increases the uncertainties.

It is therefore preferable to avoid this type of association.

OHP during pregnancy or breastfeeding

As a precautionary measure, products containing new or insufficiently studied psychoactive cannabinoids should be avoided during pregnancy and breastfeeding.

They must also be kept strictly out of reach of children.

OHP and dependency

There is insufficient specific data to determine the potential for dependence of OHP.

It would therefore be incorrect to present this cannabinoid as "non-addictive".

For psychoactive substances in general, repeated use can lead to a change in habits and an increase in tolerance in some people.

Difficulty in reducing or stopping use should be taken seriously.

Why should OHP opinions be put into perspective?

The searches "OHP reviews" reveal the curiosity surrounding new cannabinoids.

Testimonies can be helpful in understanding what some people say they have felt.

However, they do not constitute scientific studies.

Several factors make their interpretation difficult.

The user may not necessarily know the exact composition of the product.

The quantity may vary.

Two brands can use different formulations under a similar name.

Individual sensitivity also plays a considerable role.

A testimony therefore does not allow us to define a universal property of the OHP.

How to evaluate the quality of an OHP product?

For neo-cannabinoids, quality control must go far beyond a photograph or an attractive strain name.

Several pieces of information are worth researching:

The composition

The product must be described clearly enough.

The concentration

The stated percentage should ideally be verifiable.

The batch number

It ensures traceability.

The certificate of analysis

It provides objective information on the sample analyzed.

The manufacturer or supplier

Supply chain traceability is important.

Warnings

A serious product should not minimize the necessary precautions.

Why Buddha Farm's prioritizes information and transparency

The cannabinoid market is evolving extremely rapidly.

In this context, simply offering a product name and a percentage is no longer sufficient.

Buddha Farm's aims to support its different categories with information that allows for a better understanding of the products offered.

For new cannabinoids like OHP, this means, in particular, distinguishing marketing claims from actually established information.

Transparency also involves regularly updating information when regulations or available knowledge evolve.

OHP FAQ: Frequently Asked Questions

What is OHP?

OHP is a term used in the new cannabinoid sector. This term does not currently benefit from the same level of public standardization as CBD, CBG, or delta-9-THC. To know precisely what an OHP product contains, its composition and analysis must be consulted.

What does OHP mean?

The exact meaning must be provided by the manufacturer of the formulation in question. It is not advisable to invent a chemical name developed solely from the acronym.

Is OHP a cannabinoid?

OHP products are marketed in the neo-cannabinoid category. However, analytical composition is still necessary to precisely identify the corresponding substance or formulation.

What are the effects of OHP?

Specific scientific data are currently insufficient to establish a precise and universal effect profile. Testimonials available online should not be confused with clinical data.

Is OHP psychoactive?

It depends on the actual composition of the product. As a precaution, a cannabinoid formulation marketed to produce noticeable effects should be considered as potentially impairing alertness.

Is OHP stronger than CBD?

This comparison is not scientifically relevant without precisely identifying the substance. Furthermore, CBD has a much better documented pharmacological profile.

Is OHP more potent than THC?

No reliable equivalence should be announced without comparative pharmacological data relating to the precisely identified molecule.

What is the difference between OHP and HHC?

HHC stands for hexahydrocannabinol, a defined molecule. OHP is a more recent commercial name whose composition needs to be specified. The two terms are not synonymous.

What is the difference between OHP and 10-OH-HHC?

10-OH-HHC refers to a hydroxylated compound related to HHC. OHP should not be automatically equated with 10-OH-HHC without manufacturer documentation or analysis confirming this identity.

Is OHP legal in France?

The status cannot be determined solely from the trade name OHP. The substance and composition of the product must be precisely identified and then compared to the applicable French regulations.

Can we buy a product simply because it is presented as "legal OHP"?

Commercial expression does not constitute legal proof. Status must be based on the actual chemical identity of the product and the regulations applicable at the time in question.

Does an OHP flower naturally contain OHP?

Not necessarily. In the neo-cannabinoid sector, a flower can serve as a base for a formulation applied after harvest. The manufacturer must provide transparent information about the composition.

What does OHP 20% mean?

This generally indicates a stated concentration of 20% for the formulation in question. Ideally, this figure should be confirmed by laboratory analysis.

Does OHP 20% mean 20% THC?

No. A stated concentration of OHP should not be equated with an equivalent content of delta-9-THC.

Can we compare the percentages between different cannabinoids?

Not directly. Two molecules present at the same concentration can have different pharmacological properties.

Why request an OHP analysis certificate?

The certificate allows, in particular, verification of the cannabinoids detected, their concentrations and, depending on the analyses carried out, various quality parameters or contaminants.

Is it safe to drive after using OHP?

As a precaution, avoid using this product if it may have psychoactive effects or impair alertness. Driving and operating machinery require intact faculties.

Can HPO be detected in a saliva test?

A negative test result can never be guaranteed. The actual composition of the product, the possible presence of THC, metabolism, and the characteristics of the test can all play a role.

Is OHP safe?

No new and insufficiently studied substance should be presented as completely safe. The lack of data itself represents uncertainty.

Are there any scientific studies on OHP?

Under this specific trade name, the scientific information needed to establish a complete pharmacological profile is currently insufficient. The exact chemical identity must first be established.

OHP: What you need to know

OHP is one of the new names that have appeared in the particularly dynamic world of neo -cannabinoids .

Its arrival naturally sparks numerous searches: OHP cannabinoid, OHP effects, OHP reviews, OHP France, OHP legal, OHP vs CBD, OHP vs THC or even OHP flowers.

But the new approach also requires greater transparency.

Unlike CBD, CBG or delta-9-THC, the OHP designation does not currently allow the consumer to identify with sufficient certainty a scientifically standardized molecule simply from its trade name.

Priority should therefore be given to the actual composition of the product, laboratory analyses, batch number and traceability.

Caution should also be exercised regarding claims about its effects, potency, and safety until sufficient specific scientific data are available.

Finally, the question "Is OHP legal in France?" cannot be answered definitively based solely on the acronym OHP. Its legal status depends on the chemical identity and exact composition of the product, as well as the French regulations in force at the time of its marketing.

For an OHP category, transparency must therefore remain the central principle: knowing precisely what each reference contains before drawing conclusions about its properties or status.

Products intended for adult use only. Keep out of reach of children. Not recommended during pregnancy or breastfeeding. Do not drive or operate machinery after using a product that may impair alertness. If you are taking medication, consult a healthcare professional.